Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Tablets – lozenges – or pills
Reexamination Certificate
2006-04-04
2006-04-04
Page, Thurman K. (Department: 1618)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Tablets, lozenges, or pills
C424S464000, C424S465000, C424S468000, C424S472000, C424S474000
Reexamination Certificate
active
07022342
ABSTRACT:
A sustained release beta-adrenergic receptor blocking agent, preferably propranolol, formulation.
REFERENCES:
patent: 3337628 (1967-08-01), Crowther et al.
patent: 4138475 (1979-02-01), McAinsh et al.
patent: 4248856 (1981-02-01), Guley et al.
patent: 4248857 (1981-02-01), DeNeale et al.
patent: 4248858 (1981-02-01), Guley et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4309406 (1982-01-01), Guley et al.
patent: 4394390 (1983-07-01), Hussain et al.
patent: 4443428 (1984-04-01), Oshlack et al.
patent: 4469690 (1984-09-01), Ackerman et al.
patent: 4470987 (1984-09-01), Wurtman et al.
patent: 4522804 (1985-06-01), Dunn
patent: 4600708 (1986-07-01), Reuter et al.
patent: 4681765 (1987-07-01), Guley
patent: 4711887 (1987-12-01), Briggs et al.
patent: 4728512 (1988-03-01), Mehta et al.
patent: 4780318 (1988-10-01), Appelgren et al.
patent: 4783444 (1988-11-01), Watkins et al.
patent: 4792452 (1988-12-01), Howard et al.
patent: 4883660 (1989-11-01), Blackman et al.
patent: 4888354 (1989-12-01), Chang et al.
patent: 4898737 (1990-02-01), Panoz et al.
patent: 4906635 (1990-03-01), Neustadt et al.
patent: 4931283 (1990-06-01), Tsuk
patent: 4933184 (1990-06-01), Tsuk
patent: 4952402 (1990-08-01), Sparks et al.
patent: 4983401 (1991-01-01), Eichel et al.
patent: 4988736 (1991-01-01), Foldesy
patent: 5026559 (1991-06-01), Eichel et al.
patent: 5095151 (1992-03-01), Guley et al.
patent: 5133974 (1992-07-01), Paradissis et al.
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5242949 (1993-09-01), Goldberg et al.
patent: 5268182 (1993-12-01), Brinker et al.
patent: 5376384 (1994-12-01), Eichel et al.
patent: 5387613 (1995-02-01), Goldberg et al.
patent: 5478573 (1995-12-01), Eichel et al.
patent: 5498636 (1996-03-01), Goldberg et al.
patent: 5525347 (1996-06-01), Kellner et al.
patent: 5700410 (1997-12-01), Nakamichi et al.
patent: 5773023 (1998-06-01), Deckner et al.
patent: 5783215 (1998-07-01), Arwidsson et al.
patent: 5830497 (1998-11-01), Yamanaka et al.
patent: 5851555 (1998-12-01), Sanghvi et al.
patent: 5881926 (1999-03-01), Ross
patent: 5919828 (1999-07-01), Weglicki
patent: 5932572 (1999-08-01), Dean et al.
patent: 5945125 (1999-08-01), Kim
patent: 5968554 (1999-10-01), Beiman et al.
patent: 5985317 (1999-11-01), Venkateshwaran et al.
patent: 6046177 (2000-04-01), Stella et al.
patent: 6270805 (2001-08-01), Chen et al.
Chen Chih-Ming
Cheng Xiu Xiu
Andrx Corporation, Inc.
Hedman & Costigan ,P.C.
Page Thurman K.
Young Micah-Paul
LandOfFree
Controlled release oral dosage form of beta-adrenergic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release oral dosage form of beta-adrenergic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release oral dosage form of beta-adrenergic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3589541